Summary: Postischemic brain reperfusion is associated with a substantial and long-lasting reduction of protein synthesis in selectively vulnerable neurons, Because the overall translation initiation rate is typically regulated by altering the phosphory lation of serine 51 on the a-subunit of eukaryotic initiation factor 2 (eIF-2a), we used an antibody specific to phosphory lated elF-2a ] to study the regional and cellular dis tribution of eIF-2( aP) in normal, ischemic, and reperfused rat brains, Western blots of brain postmitochondrial supernatants revealed that -1 % of all elF-2a is phosphorylated in controls, eIF-2(aP) is hot reduced by up to 30 minutes of ischemia, and eIF-2(aP) is increased -20-fold after 10 and 90 minutes of reperfusion, Immunohistochemistry shows localization of eIFNeurons of the CA I and hilar regions of the hippo campus and layers III, V, and VI of the cerebral cortex have been deemed "selectively vulnerable" because of their inordinate sensitivity to transient ischemia. Mor phologic studies have shown that disaggregation of poly ribosomes, a hallmark of translation initiation inhibition (van Venrooij et al., 1972) , is among the earliest changes during reperfusion in these regions (Jenkins et aL, 198 , 1977; Dienel et a1., 1980; Bodsch et al., 1985 Bodsch et al., , 1986 Yoshidomi et al., 1989; Widmann et al., 199 1; DeGracia et al., 1996) support the contention that its suppression is an early event (Nowak et a1., 1985; Araki et aI., 1990), and its restoration may play an important role in neuronal survival after transient ischemia (Thil mann et al., 1986). It is now generally accepted that this depression of protein synthesis is a result of inhibition of translation initiation (Krause and Tiffany, 1993) .
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Formation of the translation-initiation complex re quires the coordinated assembly of the ribosomal sub units, the mRNA to be translated, and the tRNA coding for the first amino acid (methionine in eukaryotic cells); this process is orchestrated by a family of proteins col lectively known as eukaryotic initiation factors (elF) (Merrick, 1992) . Rates of global protein synthesis are regulated by altering the phosphorylation state of eIF-2, which introduces the initiator methionyl-tRNA into the translation-initiation complex (Redpath and Proud, 1994) , Phosphorylation of serine 51 on the a-subunit of e1F-2 [eIF-2(aP)] generates a competitive inhibitor of eukaryotic initiation factor 2B and thereby prevents the replenishment of GTP onto eIF-2, which is necessary for each round of translation initiation (Rowlands et aI., 1988) . In several systems, increased eIF-2(aP) results in decreased protein synthesis (Pain, 1996) , and studies from our laboratory (DeGracia et aI., 1996) and from Burda et al. (1994) reported enhanced phosphorylation of elF-2a in brain homogenates obtained after reperfusion.
In the present study, we have developed an antibody to serine-51-phosphorylated elF-2a and used this antibody to characterize the effects of ischemia and reperfusion on eIF-2(aP) in brain homogenates and to localize elF-2(aP) in perfusion-fixed brain sections from normal, ischemic, and reperfused brains.
MATERIALS AND METHODS

Antibody preparation and characterization
Polyclonal antibody against eIF-2(aP) was generated (Re search Genetics, Huntsville, AL) in New Zealand White rab bits using the synthetic phosphorylated (bold) peptide lLLSELSRRRIRS conjugated to keyhole limpet hemocyanin.
This sequence corresponds to amino acids 45 to 57 and is perfectly conserved around the phosphorylation site in human, Drosophila, and Saccharomyces cerevisiae eIF-2a (Qu and Cavener, 1994) . The antisera was affinity purified against col umn-bound phosphorylated peptide and eluted using a pH gra dient. The eluant was then passed through the nonphosphory lated peptide column and the flow-through, depleted of cross reacting antibtJdies, was collected. Purified unphosphorylated e1F-2 and a monoclonal antibody against elF-2a that recog nizes both the phosphorylated and unphosphorylated forms were generous gifts from Susan Oldfield (University of Bristol, Bristol, U.K.). Partially purified elF-2a kinase (heme controlled repressor, HCR) was a generous gift from Scot Kim ball (Pennsylvania State University, Hershey, PA, U.S.A.). All other chemicals were reagent grade.
The selectivity of our antibody for eIF-2(aP) was determined by immunoreactivity toward phosphorylated and unphosphory lated eIF-2a on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and isoelectric focusing-PAGE (lEF). We used HCR and 1'-3 2 p_ATP to phosphorylate purified e1F-2 at Ser51 on the a-subunit by the method of Kimball et al. (1991) . Reactions (25 f,lL) contained 8 f,lg of e1F-2 in a buffer of 2 mmollL magnesium acetate, 5 mmollL dithiothreitol, 300
ethanesulfonic acid] (HEPES, pH 7.45) and 44 fLmollL labeled ATP (specific activity 40 dpm/fmol). The reaction was initiated by adding 2 fLL HCR and incubated at 37°C for 35 minutes;
control reactions omitted HCR. Incorporation was confirmed as trichloroacetic acid precipitable radioactivity on fiberglass fil ters. Reaction aliquots containing either 100 or 10 ng of labeled and unlabeled elF-2a were electrophoresed on a 12.5% SDS polyacrylamide gel. The proteins were transferred to nitrocel lulose (0.45 f,lm), and the membrane was fixed, dried, and autoradiographed (5-day exposure). This membrane was then immunoblotted with anti-eIF-2(aP), stripped (100 mmol/L 2-mercaptoethanol, 2% SDS, 62.5 mmollL Tris-HCl, pH 6.7), and reprobed with anti-eIF-2a (3-minute exposure).
Antibody specificity was determined by examining brain postmitochondrial supernatants (PMS) to see whether the anti body identified a single band after SDS-PAGE and immunob lotting (described below) and whether the reperfusion-induced shift in lEF-PAGE migration of elF-2a (Burda et aI., 1994; DeGracia et aI., 1996) was caused by its phosphorylation on (Maurides et aI., 1989) , After prefocusing, the wells were thoroughly washed with distilled water and the tank buffers were replenished, Samples (25 f,lg protein) in a loading buffer of 9 mollL urea, 3% ampholines, and 5% CHAPS were run beginning at 500 V with a 50-V increase every 30 minutes to 750 V and then a final step to I 000 V for an additional 30 minutes. Proteins were transferred t� nitrocellulose, and the membranes were fixed and immuno blotted as described above,
Animal Model
All animal experiments were approved by our institutional review board and were conducted following the "Principles of Laboratory Animal Care" (NIH publication No. 86-23, revised 1985) , Male Long Evans rats weighing 425 to 500 g were anesthetized with ketamine and xylazine, and catheters were placed for vascular access. Animals were monitored for arterial pressure, ECG, and core temperature, and subjected to com plete global brain ischemia and reperfusion by cardiac arrest and resuscitation with intensive care after arrest as previously described (DeGracia et aI., 1996) , mmollL NaF, 7 f,lg/mL pepstatin A, I f,lg/mL aprotinin, and 10 fLg/mL leupeptin) and homogenized in a hand-held Dounce homogenizer with five volumes of ice-cold buffer. The homog enate was centrifuged at 17,000g for 10 minutes at 4°C, and after an aliquot was taken for protein determination by the Folin phenol reagent method, the supernatant was rapidly fro zen on dry ice and ethanol and stored at -80°C, Samples con taining 50 f,lg protein were added to an equal volume of 2x SDS-PAGE loading buffer, boiled for 2 minutes, electropho resed on 12,5% T SDS-polyacrylamide gels, and transferred electrophoretically to nitrocellulose, The membranes were fixed in 25% isopropanol and 12,5% acetic acid for 20 minutes, rinsed, and blocked in 5% nonfat milk in TTBS (l00 mmollL 
Immunoblotting of brain PMS
RESULTS
Characterization of the eIF-2(aP) antibody
The selectivity of our anti-eIF-2(aP) was first exam ined on Western blots of native elF-2a and of elF-2a after in vitro phosphorylation (Fig. I) . The autoradio gram of this membrane (Fig. lA) shows that elF-2a was phosphorylated only in the presence of HCR (lanes I and 2). Immunoblotting with the antibody that recognizes both phosphorylated and unphosphorylated elF-2a showed that both forms were present on this membrane (Fig. IB) . Our antibody, raised against a synthetic pep tide corresponding to the phosphorylated SerS I site of the a-subunit of eIF-2, recognized only eIF-2(aP) (Fig I C, lanes I and 2) .
The specificity of our anti-eIF-2(aP) was examined on Western blots of brain PMS subjected to IEF-PAGE and SDS-PAGE (Fig. 2) . As we have previously reported (DeGracia et aI., 1996) , after IEF-PAGE of normal and 90-minute reperfused brain PMS, an immunoblot with the non-phosphorylation-specific anti-eIF-2a shows the presence of a doublet in all of the reperfused samples ( Fig. 2A-I) , with the new upper band displaced toward more acidic pH. There was no change in total e1F-2 between the two groups. When this membrane was rep- (PMS, 50 �g protein) from three normal rats (lanes 1 through 3) and three rats subjected to a 1 O-minute cardiac arrest followed by 90 minutes of reperfusion (lanes 4 through 6) were subjected to IEF-PAGE (see Methods). After the proteins were transferred to nitrocellulose, the membrane was immunoblotted with anti-eIF2a (1), stripped, and immunoblotted with anti-eIF-2(aP) (2). Ar rowheads provide alignment for the position of eIF-2(aP), which is shifted toward more acid pH. The eIF-2(aP) antibody detects only the phosphorylated eIF-2a. Densitometry shows that about 1 % of elF-2a is phosphorylated in the normal brain PMS and eIF-2(aP) is increased 24-fold after 90 minutes of reperfusion. (8)
Postmitochondrial supernatants (50 �g protein) from control (lanes 1 through 3), 10 minutes of ischemia and 10 minutes of reperfusion (lanes 4 through 6), and 10 minutes of ischemia and 90 minutes of reperfusion (lanes 7 through 9) brains were elec trophoresed on a 12.5% SDS-polyacrylamide gel. After the pro teins were transferred to nitrocellulose, the membrane was im munoblotted with a 1:1,000 dilution of anti-eIF-2(aP). The elF-2(aP) antibody detects a single band at 36 kDa (1) and this signal is ablated if the antibody is preblocked with 55 nmol/L peptide antigen (2). Molecular size markers (in kDa) are shown on the left. Densitometry reveals a 19-fold increase in eIF-2(aP) after 10 minutes of reperfusion (P = .0002 versus control) and a 23-fold increase after 90 minutes of reperfusion (P = .00006 versus con trol; P = 0.15 versus 10 minutes of reperfusion).
robed with the antibody specific to eIF-2(aP) ( Fig. 2A-2 ), only the upper band of the elF-2a signal was recog nized. This result shows that the upper band seen in the reperfused samples is elF-2a that has been phosphory lated on Ser5l. Furthermore, examination of normal and reperfused brain PMS by SDS-PAGE and immunoblot ting with our anti-eIF-2(aP) shows only one band mi grating at 36 kDa (Fig. 2B) . The intensity of this band is greatly enhanced after reperfusion (Fig. 2B-I) , and its signal is ablated by preblocking the primary antibody with 55 nmollL antigenic peptide ( Fig. 2B-2 ).
The effect of ischemia and reperfusion on eIF-2(aP) in brain PMS
We used SDS-PAGE and Western blots to examine the effects of 3 to 30 minutes of global brain ischemia on the content of eIF-2(aP) in brain PMS. Our anti-eIF-2(aP) revealed a small amount of eIF-2(aP) in normal brain PMS ( Fig. 2A-2 , lanes 1-3) that was not detected by the non-phosphorylation-specific antibody ( Fig. 2A-1 ). Densitometry shows that after 90 minutes of reper fusion eIF-2(aP) accounts for 24% ± 3% of elF-2a ( Fig.  2A-I ) and is increased 23-fold over eIF-2(aP) seen in normal brain PMS ( Fig. 2A-2 ). Therefore we estimate that eIF-2(aP) is normally about 1% of the total brain PMS eIF-2a.
We antictpated that dephosphorylation reactions would predominate during ischemia, thereby leading to a decrease in eIF-2(aP). Although the data suggest that eIF-2(aP) levels may increase between 3 and 7.5 minutes of ischemia (Fig. 3) The specificity of our antibody, as demonstrated above, allowed us to map eIF-2(aP) in normal, ischemic, and reperfused brain sections.
Nonischemic controls. In frontal sections of nonisch emic brains, eIF-2(aP) is localized exclusively in astro cytes in all of the brain areas examined, including those in cerebral cortex, hippocampus, striatum, and dien cephalon, as well as those in the white matter (Fig. 4A) . At higher power the nucleus of astrocytes is strongly immunolabeled whereas the cytoplasm contains enough label to reveal the branching pattern of the processes (Fig. 5A ). Astroglial staining is particularly evident within the large tracts of white matter, such as in the corpus callosum, in which labeled astrocytes stand out readily from the rows of unlabeled oligodendrocytes and the bundles of nerve fibers (Fig. 5B) . Recognition of the labeled cells as astrocytes is further confirmed by iden tification of their processes forming the sheaths that serve to isolate the neuronal compartment. For example, in some instances, immunolabeled astroglial processes (Fig. 5C ) can be followed to the outer glial limitans on the surface of the hemisphere (Fig. 5C, arrowhead) , which is most likely stained from the accumulation of overlapping astroglial processes. Similarly, the perivas cular glial sheath that surrounds blood vessels shows enhanced immunostaining. Thus at high-power magnifi cation, some labeled astrocytic processes are followed from the cell body to their termination as broad foot plates (i.e., endfeet) that appose to the outer perimeter of the blood vessel wall (Fig. 5D ).
Tissue after 10 minutes of ischemia. In frontal sections of brains subjected only to 10 minutes ischemia, there is weak immunolabeling for eIF-2(aP) throughout the cell layers of the CA fields and the dentate gyrus (Fig. 4B ). Higher power objectives reveal weak, homogeneous staining that is restricted to the cytoplasm of neurons in the pyramidal cell layers of CA I to CA3 as well as to that of granule cells in the dentate gyrus. In contrast the nu clei of these cells and all types of glia are unstained. This staining differs from the granular or punctate staining seen in reperfused brains (see below) and could represent eIF-2(aP) that may have been formed using residual ATP during the ischemic insult. OG. The dark staining in the alveus and fimbria is nonspecific fiber staining from the diaminobenzidine chromogen used. (C) Hippocampus after 10 minutes of ischemia and 10 minutes of reperfusion. Note that the strong immunostaining in the CA 1 cell body layer abruptly ceases at the beginning of the CA2 field (arrow). Moderate staining is seen in the granule cell layers of the dorsal and ventral blades of OG. (0) Hippocampus after 10 minutes of ischemia and 60 minutes of reperfusion. Overall a significant qualitative increase of immuno staining in the hippocampus occurs at this time point as compared with that seen in the tissues after 10 minutes of reperfusion or the 10 minutes of ischemia alone. Strong eIF-2(aP) immunostaining is present in the CA1 and CA3 fields, but not in the CA2 field (arrow). This staining is confined to the nucleus and cytoplasm of CA1 and CA3 neurons while being absent in astroglia. (E) Hippocampus after 10 minutes of ischemia and 4 hours of reperfusion. There is an overall qualitative decrease in eIF-2(aP) immunostaining in all the CA fields and hilus compared with the previous time pOint. However, eIF-2(aP) staining is now confined entirely to the nucleus of neurons in the CA 1 and CA3 fields and the hilus (see also found in the cytoplasm of selectively vulnerable neurons in the CA I and CA3 hippocampal fields. In contrast the nuclei of the same neurons show no immunolabeling. Astroglia show little labeling whereas other types of glia lack labeling altogether. In the dorsal hippocampus strong labeling occurs in the perikaryon of most pyrami dal neurons in the CAl field (Fig. 6A ) and in some neurons in the stratum oriens (Fig. 6A, arrow) . Some labeled cell bodies in the strata oriens, radiatum, lacuno sum, and moleculare suggest that varieties of hippocampal interneurons may be affected by the same sequelae affecting the pyramidal neurons after ischemia reperfusion. A more complex labeling pattern exists among the granule cells of the dentate gyrus in which some perikarya are strongly immunolabeled and many others are weakly labeled or unlabeled (Fig. 6B) . At higher power the CA 1 pyramidal neurons exhibit punc tate or granular staining in a perikaryal zone adjacent to the nuclear envelope (Fig. 6C, arrows) . In addition, the label extends to the proximal processes, in particular in the area at the base of the apical dendrite. Although the CA2 field contains unlabeled neurons, CA3 has neurons with varying labeling intensities. When strong label is present in a CA3 neuron, it is associated with numerous dark granules with a pattern reminiscent of the fine Nissl substance (Fig. 6D , arrows) . Hilar cells present a con trasting pattern in that some cells are strongly immuno labeled whereas others are unlabelled. Similar to the hip pocampal neurons, immunostaining in the cerebral cor tex is confined mostly to the perikaryal cytoplasm and to the proximal dendrites of pyramidal neurons. Labeled pyramidal neurons are found in layers Ill, V, and VI, with those in layer V being of the large and medium sizes (Fig. 6E) . Labeling intensities vary among pyramidal neurons, including some faintly labeled cells (Fig.  6E, arrows) that are hard to distinguish from unlabeled neurons. Close to the surface, an astro· cyte (arrow) radiates a process that joins the glial limitans (at arrowhead) the sections that is easily seen by ad· justing the focus of the microscope. This montage was generated from one sample by combining exposures taken at two different focal planes. (0) High-power magnification of a blood vessel in the outer molecular layer of CA 1 near the hippocampal fissure. Two immunolabeled astrocytes (ar rows) extend processes that termi nate as foot processes (large arrow heads) forming part of the perivascu lar sheath. Scale bar, 10 IJm. This montage was generated from one sample by combining exposures taken at two different focal planes.
Tissue after 10 minutes of ischemia and 1 hour of repeifusion. By I hour of reperfusion a different pattern of eIF-2(aP) emerges from that seen at 10 minutes of reperfusion. The label is visualized now in both the nucleus and cytoplasm of the selectively vulnerable neu rons (Fig. 7a) . Faint labeling occurs only in astroglia nuclei but not in the other glial types. In CA 1 most neurons are strongly labeled in both the nucleus and cytoplasm although the boundaries of the perikaryon ap pear indistinct. At higher power the nuclear label in CA 1 pyramids is associated mostly with the nuclear envelope and the heterochromatin (Fig. 7B, arrows) . A few neu rons (Fig. 7, large arrowhead) , as well as oligodendroglia (Fig. 7, small arrowhead) in the same field are not la beled. In contrast to CAl the majority of CA2 neurons remain unlabeled (Fig. 7, C) , as are the granule cells of the dentate gyrus (Fig. 7, D) . The contrasting pattern Many large and medium size pyrami dal neurons are immunolabeled whereas others are weakly labeled or unlabeled (arrows). Like hippocampal neurons, the label is confined mostly to the cytoplasm of the perikaryon and the proximal dendrites.
found in the hilus at 10 minutes of reperfusion is also maintained at I hour of reperfusion. It is possible to see in the same field some neurons strongly immunolabeled next to a cell with no label (Fig. 7E, large arrowhead) . It should be noted that the nuclear chromatin in some of the strongly labeled hilar cells appears clumped at this time point. Among the neurons of the cerebral cortex many pyramidal cells in layers III, V, and VI remain labeled, but neighboring cells in the same layers often remain unlabeled.
Tissue after 10 minutes of ischemia and 4 hours of reperfusion. By 4 hours of reperfusion most of the eIF-2(aP) label is confined to the nuclei of selectively vul nerable neurons of the same areas as above (Fig. 8) . Thus the labeling at this time point is found among neurons in CA I, CA3, hilus, and layers III, V, and VI of the cerebral cortex. In contrast no immunostaining is found among the granule cells of the dentate gyrus. However high power analysis of the nuclei of CAl neurons at this time reveals that the heterochromatin has become coarse and seemingly condensed (Fig. 8B , arrows, compare also with Fig. 7B) . A minor enhancement of the heterochro matin in granule cells of the dentate gyrus (Fig. 8C ) and in cortical neurons (Fig. 8E, 8F ) is also distinguished. Extreme condensation of the heterochromatin is found among cells of the hilus, giving the nucleus a pyknotic appearance (Fig. 8D) . In addition, lightly labeled neurons in the cerebral cortex often lack their characteristic py ramidal shape and their overall volume appears dimin ished compared with that of unlabeled neighboring neu rons (Figs. 8E, 8F) . The apparent condensation of the nuclear heterochromatin of both the labeled cortical and CAl neurons is suggestive of a state of pyknosis or an early stage of programmed cell death.
DISCUSSION
In this work we have shown (1) an antibody specific for serine-51-phosphorylated eIF-2a , (2) localization of eIF-2(aP) to astrocytes in normal brains , (3) a massive increase in eIF-2(aP) in the cytoplasm of neurons within the first 10 minutes of reperfusion , (4) accumulation of eIF-2(aP) in the nuclei of selectively vulnerable neurons after I hour of reperfusion , and (5) morphology suggest ing pyknosis or apoptosis in neuronal nuclei that con tinue to display eIF-2(aP) after 4 hours of reperfusion. These observations , together with the fact that eIF-2(aP) inhibits translation initiation (Merrick , 1992) , make a compelling case that eIF-2(aP) is responsible for reper fusion-induced inhibition of protein synthesis in vulner able neurons (Thilmann et aI. , 1986) . 2( aP) and apoptosis or pyknosis are suggested by the morphology of neurons that continue to exhibit elF-2( aP) after 4 hours of reperfusion.
The temporal and spatial profiles of eIF-2(aP) closely follow the expected inverse relationship to postischemic brain protein synthesis reported by others. Thilmann et al. (1986) studied regional protein synthesis in autora diograms of gerbil forebrains after 5 minutes of ischemia and 30, 90, 180, or 360 minutes of reperfusion. They found that protein synthesis was almost completely sup pressed after 30 minutes of reperfusion in all areas of the forebrain , but with longer reperfusion , protein synthesis gradually recovered , except in the CAl. The most resis tant areas (e.g. , dentate gyrus) recovered first, and the more sensitive areas (e.g. , hilus) recovered last. We found gradual reduction in cytoplasmic eIF-2(aP) at 60 minutes and 4 hours of reperfusion with the dentate gy- rus showing the earliest recovery , but eIF-2(aP) re mained elevated in CAl after 4 hours of reperfusion.
We were surprised to note eIF-2(aP) immunostaining in nuclei of selectively vulnerable neurons after I and 4 hours of reperfusion. Although in very early reperfusion cytoplasmic eIF-2(aP) was seen in vulnerable as well as ischemia-resistant neurons , we never observed eIF-2(aP) in the nuclei of non vulnerable neurons. To verify that the nuclear staining was not caused by a protein other than eIF-2(aP) , we immunoblotted un fractionated forebrain homogenates from tissue after I hour of reperfusion with anti-eIF-2(aP) and again observed only one band migrat ing at 36 kDa (not shown). Although eIF-4E (Lejbkow icz et aI., 1992) and elF-SA (Ruhl et aI., 1993) have been previously observed in the nucleus , eIF-2 has not. While eIF-2a has no sequence elements expected to react with nucleotides , the [3-subunit of eIF-2 possesses a C 2 /C 2 zinc finger motif (Donahue et aI. , 1988) and contains three blocks of six to eight lysine residues that may be involved in binding nucleic acids (Pathak et aI. , 1988) . Indeed the zinc finger region of eIF-2[3 binds tRNA (Flynn et aI. , 1994 ) and also appears to be involved in recognition of the start codon on mRNA (Donahue et aI., 1988) . These characteristics of the [3-subunit and our observation of eIF-2(aP) in the nuclei of selectively vul nerable neurons after I hour of reperfusion raise the pos sibility that eIF-2 interacts with DNA under conditions of cellular stress.
Potential mechanisms involved in the accumulation of eIF-2(aP) during reperfusion
The increase in eIF-2(aP) during early reperfusion re quires an active eIF-2a kinase; the only three known are GCN2, HCR, and PKR (Samuel , 1993) . GCN2 is found in yeast, but a mammalian analog has not been reported (Wek, 1994) . Studies in the rabbit reticulocyte transla tion system revealed an elF-2a kinase now known as HCR (heme-controlled repressor). The activity of this enzyme is stimulated by heavy metals (e.g., iron [Hurst et aI., 1987] ) and Jipoperoxides (De Herreros et aI., 1985) , and this suggested HCR could be activated by radical-mediated iron delocalization and lipid peroxida tion during brain reperfusion (White et aI., 1993) . Be cause oxidized glutathione is known to activate HCR (Clemens et aI., 1975) , we examined in vitro translation systems (DeGracia et aI., 1996) in which' oxidized glu tathione was added to either a rabbit reticulocyte lysate or to a normal rat brain homogenate. We obtained the expected translation inhibition in the rabbit reticulocyte system, but oxidized glutathione had no effect on trans lation in the rat brain homogenate (unpublished data). This result and the studies of Pal et al. (1991) argue against HCR as a major regulator of eIF-2a phosphory lation in the brain.
PKR (formerly DAI, p68 kinase, PKds, or Pl/elF-2a protein kinase) is widely distributed in various tissues, including the brain (Haines et aI., 1993) . It is tightly associated with ribosomes (Samuel, 1993) and in ultra structural studies is seen on the rough endoplasmic re ticulum (ER)I- (Schwemmle et aI., 1992) with a small fraction present in the nucleolus (Jeffrey et aI., 1995) . The eIF-2a kinase function of PKR is activated by auto and transphosphorylation on several serine and threonine sites (Thomas and Samuel, 1995; Taylor et aI., 1996) , and a number of endogenous activators and inhibitors of PKR have been identified (Jagus, 1994) .
One mechanism by which PKR could be activated during brain ischemia and early reperfusion involves ara chidonate-mediated depletion of calcium from the ER. Free arachidonic acid exceeds 100 /-1mollL within 10 minutes of brain ischemia and does not recover to base line levels for at least the first 30 minutes of reperfusion (Abe et aI., 1989) . Arachidonate can induce release of calcium from ER stores (Wolf et a!., 1986; Katsuki and Okuda, 1995) , and several studies have shown that depletion of Ca 2 + from the ER induces activation of PKR (Prostko et a!., 1995) and a rapid suppression of protein synthesis (Brostrom et a!., 1983 (Brostrom et a!., , 1985 (Brostrom et a!., , 1989 Chin et aI., 1987; Kumar et a!., 1989) . Indeed, free arachidonate con centrations greater than 10 /-1mol/L in cell culture models lead to PKR activation, elF-2a phosphorylation, and suppression of protein synthesis (Rotman et aI., 1992; Fleming and Mellow, 1995) . PKR activity is not directly affected by Ca 2 +, and the mechanisms responsible for PKR activation as a consequence of Ca 2 + depletion from the ER are unknown. PKR activation is possible despite the rapid loss of A TP during ischemia because the I /-1mol/L ATP needed for PKR autophosphorylation (Hu and Conway, 1993 ) is three orders of magnitude less than J Cereb Blood Flow Me/ab, Vol. 17, No. 12, 1997 the 3 mmollL ATP in normal neurons (Lowry et aI., 1964) . This situation could allow PKR activation during ischemia with the majority of phosphorylation of elF-2a delayed until A TP recovers during reperfusion. Our data showed a trend, which did not reach statistical signifi cance, suggesting that there is an increase in elF-2a ki nase activity during ischemia, which might explain in part the very rapid phosphorylation of eIF-2a we have observed during reperfusion.
The persistently enhanced phosphorylation of elF-2a during brain reperfusion might also reflect inappropri ately low phosphatase activity against eIF-2(aP). There are four major classes of serine-threonine protein phos phatases (PP) based on their catalytic subunits and re sponsiveness to various inhibitors (Cohen, 1989) . PPI and PP2A, but not PP2B or PP2C, dephosphorylate eIF-2(aP) in vitro (Ingebritsen and Cohen, 1983) , and the addition of okadaic acid (an inhibitor of PPI and PP2A) to cells results in shutdown of protein synthesis (Redpath and Proud, 1990 ). PPI appears to be the dominant phos phatase for eIF-2(aP) (Babu and Ramaiah, 1996) and also dephosphorylates PKR (Szyszka et aI., 1989) . PPl, but not PP2A, is specifically inhibited by two peptides (1-1 and 1-2) (Cohen, 1989) , and in the reticulocyte ly sate, addition of either I-l or 1-2 leads to increased phos phorylation of elF-2a and inhibition of translation (Ernst et aI., 1982) .
The catalytic subunit of PPI (PPIC) is regulated by phosphorylation of targeting subunits or interactions with 1-1 and 1-2 (Cohen, 1989) . Targeting subunits direct PPIC to the proper subcellular location, enhance the ac tivity of PPI toward substrates, and confer sensitivity to extracellular signals (Hubbard and Cohen, 1993) . Con versely, dissociation of PP 1 into its subunits (e.g., in duced by arachidonate or epinephrine) is associated with inhibition of the activity of PPIC (MacKintosh et aI., 1988; Hubbard and Cohen, 1989; Gong et a!., 1992) . There is a greater than 30-fold increase in epinephrine levels during reperfusion after cardiac arrest (Kern et aI., 1989) , and epinephrine activates I-I (presumably through cAMP-induced protein kinase A activation; Dent et aI., 1990) . Interestingly, I-I is found mostly in the pyramidal neurons in the hippocampus and layers II to III and V to VI in rat cerebral cortex (Hemmings et a!., 1992; Lowenstein et aI., 1995) .
Potential involvement of eIF-2(aP) in the induction of apoptosis
The persistent accumulation of eIF-2(aP) that we have observed in vulnerable neurons during reperfusion may be related to the induction of apoptosis (Hale et a!., 1996) . Activated PKR induces transcription of the gene for FAS (Takizawa et a!., 1995) , and FAS protein is in creased 131-fold at 2 hours of reperfusion after myocar dial ischemia (Kajstura et aI., 1996) . In higher eukaryotes ac tivation of the FAS and tumor necrosis factor (TNF) family of cell surface receptors has been shown to trigger intracellular signaling pathways leading to apoptosis (Nagata and Golstein , 1995) . Moreover, mouse embryo fi broblasts from mice containing homozygous deletions in the PKR gene are resistant to TNF-a-induced apop tosis (Der et aI. , 1997) . There is some evidence that PKR-dependent apoptosis may be mediated by eIF-2(aP) itself. Expression of the eIF-2a mutant protein Ser S! Ala (no phosphorylation possible) in NIH 3T3 fi broblasts blocked TNF-a induced apoptosis, whereas conditional expression of the Ser S! Asp mutant (which mimics permanent phosphorylation) induced immediate apoptosis (Kaufman and Srivastava , 1996) .
